119 related articles for article (PubMed ID: 33895924)
41. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
[TBL] [Abstract][Full Text] [Related]
43. Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein-α-based doxorubicin prodrug: in-vitro and in-vivo evaluation.
Huang S; Zhang Y; Zhong J; Pan Y; Cai S; Xu J
Anticancer Drugs; 2018 Mar; 29(3):253-261. PubMed ID: 29346131
[TBL] [Abstract][Full Text] [Related]
44. A model for endosymbiosis: interaction between Tetrahymena pyriformis and Escherichia coli.
Siegmund L; Burmester A; Fischer MS; Wöstemeyer J
Eur J Protistol; 2013 Nov; 49(4):552-63. PubMed ID: 23763905
[TBL] [Abstract][Full Text] [Related]
45. Use of the ciliated protozoan Tetrahymena pyriformis for the assessment of toxicity and quantitative structure--activity relationships of xenobiotics: comparison with the Microtox test.
Bogaerts P; Bohatier J; Bonnemoy F
Ecotoxicol Environ Saf; 2001 Jul; 49(3):293-301. PubMed ID: 11440483
[TBL] [Abstract][Full Text] [Related]
46. Effect of ribosome-inactivating proteins on ribosomes from Tetrahymena pyriformis and Acanthamoeba castellanii.
Cenini P; Battelli MG; Bolognesi A; Stirpe F; Villemez CL
Biochem Biophys Res Commun; 1987 Oct; 148(2):521-7. PubMed ID: 3120707
[TBL] [Abstract][Full Text] [Related]
47. Wild edible onions - Allium flavum and Allium carinatum - successfully prevent adverse effects of chemotherapeutic drug doxorubicin.
Aleksandar P; Dragana MĆ; Nebojša J; Biljana N; Nataša S; Branka V; Jelena KV
Biomed Pharmacother; 2019 Jan; 109():2482-2491. PubMed ID: 30551509
[TBL] [Abstract][Full Text] [Related]
48. Seleno-l-methionine and l-ascorbic acid differentiate the biological activity of doxorubicin and its metal complexes as a new anticancer drugs candidate.
Matejczyk M; Świderski G; Świsłocka R; Rosochacki SJ; Lewandowski W
J Trace Elem Med Biol; 2018 Jul; 48():141-148. PubMed ID: 29773172
[TBL] [Abstract][Full Text] [Related]
49. Effect of tuftsin and oligotuftsins on chemotaxis and chemotactic selection in Tetrahymena pyriformis.
Láng O; Mezo G; Hudecz F; Kohidai L
Cell Biol Int; 2006 Jul; 30(7):603-9. PubMed ID: 16733095
[TBL] [Abstract][Full Text] [Related]
50. [The influence of epidermal growth factor and insulin on proliferation and DNA synthesis in ciliates Tetrahymena pyriformis].
Shemarova IV; Selivanova GV; Vlasova TD
Tsitologiia; 2002; 44(11):1097-103. PubMed ID: 12561730
[TBL] [Abstract][Full Text] [Related]
51. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
52. Population growth kinetics of Tetrahymena pyriformis exposed to selected nonpolar narcotics.
Bearden AP; Gregory BW; Schultz TW
Arch Environ Contam Toxicol; 1997 Nov; 33(4):401-6. PubMed ID: 9419258
[TBL] [Abstract][Full Text] [Related]
53. Different and selective chemotactic responses of Tetrahymena pyriformis to two families of signal molecules: lectins and peptide hormones.
Köhidai L; Csaba G
Acta Microbiol Immunol Hung; 1996; 43(1):83-91. PubMed ID: 8806947
[TBL] [Abstract][Full Text] [Related]
54. [Relations between the toxicity parameters of chemical substances for Tetrahymena pyriformis infusorians and animals].
Etlin SN; Lakhonina GM; Irlina IS; Popova LA; Malygin SA
Gig Sanit; 1987 Sep; (9):80-2. PubMed ID: 3119430
[No Abstract] [Full Text] [Related]
55. In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines.
Tomankova K; Polakova K; Pizova K; Binder S; Havrdova M; Kolarova M; Kriegova E; Zapletalova J; Malina L; Horakova J; Malohlava J; Kolokithas-Ntoukas A; Bakandritsos A; Kolarova H; Zboril R
Int J Nanomedicine; 2015; 10():949-61. PubMed ID: 25673990
[TBL] [Abstract][Full Text] [Related]
56. Comparative study of two in vitro models (L-929 fibroblasts and Tetrahymena pyriformis GL) for the cytotoxicological evaluation of packaged water.
Sauvant MP; Pepin D; Bohatier J; Groliere CA; Veyre A
Sci Total Environ; 1994 Nov; 156(2):159-67. PubMed ID: 7992036
[TBL] [Abstract][Full Text] [Related]
57. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
58. Structure-toxicity relationships for aliphatic isothiocyanates to Tetrahymena pyriformis.
Schultz TW; Comeaux JL
Bull Environ Contam Toxicol; 1996 Apr; 56(4):638-42. PubMed ID: 8645923
[No Abstract] [Full Text] [Related]
59. Design, synthesis, and in vitro antitumor activity of a transferrin receptor-targeted peptide-doxorubicin conjugate.
Li S; Zhao H; Fan Y; Zhao G; Wang R; Wen F; Wang J; Wang X; Wang Y; Gao Y
Chem Biol Drug Des; 2020 Jan; 95(1):58-65. PubMed ID: 31452330
[TBL] [Abstract][Full Text] [Related]
60. Imprinting effects of proline containing dipeptides (proline-glycine, proline-leucine, proline-valine and their retro variants) in tetrahymena. Evolutionary conclusions.
Csaba G; Kovács P
Biosci Rep; 1997 Dec; 17(6):537-42. PubMed ID: 9561298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
